The Biden administration has reformed Medicare, gone after bogus drug patents and pushed pharmaceutical companies to reduce ...

The U.S. Centers for Medicare & Medicaid Services (CMS) has released a preliminary list of 101 generic drugs that would be ...

In the phase 3b BATURA trial, Airsupra—a pressurized metered-dose inhaler containing albuterol and budesonide—significantly ...

India's drug pricing authority has increased the prices of essential drugs for conditions like asthma and tuberculosis, ...

The National Pharmaceutical Pricing Authority (NPPA) has sanctioned the ceiling price hike for 11 formulations by 50 per cent ...

Depemokimab has already shown its potential as a therapy for severe asthma in two other phase 3 trials – SWIFT-1 and SWIFT-2 ...

According to Research by SNS Insider, Nebulizer Market Growth is Driven by Rising Prevalence of Chronic Respiratory Diseases and Technological Advancements.Austin, Oct. 18, 2024 (GLOBE NEWSWIRE) -- ...

The medicines for which the prices have been increased are not very expensive to begin with and are not expected to hit ...

The government has increased the cost of certain essential drugs for treating asthma, tuberculosis and others.

India's drug pricing authority has hiked the prices of drugs for conditions like asthma, tuberculosis, and mental health.

Most of these drugs are low cost and generally used as first-line treatment crucial to the public health programmes of the ...

Ceiling prices were also revised for the asthma drug Salbutamol in tablets of 2 mg and 4 mg formulations and respirator ...